Diabetes: Tackling the staggering burden of this global disease
A rapidly growing epidemic, diabetes affects 1 in every 11 adults worldwide2. In 2015, an estimated 5 million people died due to diabetes-related complications3, with more than 80% of deaths occurring in developing countries4. Without effective prevention and control, diabetes will become the seventh leading cause of death globally by 20305.
Diabetes - an emerging global epidemic
- 415 million people worldwide have diabetes
- 5 million deaths due to diabetes related complications
- WHO projects that diabetes will be the 7th leading cause of death in 2030
Source: IDF Diabetes Atlas 7th ed. 2015 www.who.int/mediacentre/factsheets/fs312/
Diabetes is a manageable disease
A chronic disease affecting the body’s use of insulin, a hormone produced in the pancreas which regulates blood sugar (glucose) levels, diabetes has three major forms: type 1 is characterised by a complete lack of insulin production, type 2 results from the body's inability to effectively use insulin and the third type is gestational, which can occur during pregnancy. Simple lifestyle measures such as a healthy diet and regular exercise have been shown to effectively prevent or delay the onset of type 2 diabetes, which accounts for up to 90% of all cases6.
Diabetes can be treated with effective management, including regular self-monitoring of blood glucose levels. Increasing access to early diagnosis, self-monitoring, education and individualised treatment can greatly reduce the risk of serious short and long-term complications associated with diabetes, such as cardiovascular diseases, blindness, amputation and kidney failure, and can also reduce the costs of care shouldered by health systems and patients.1
More than 40 years experience in diabetes care
With more than 40 years of experience in diabetes care, Roche is pioneering innovative solutions to support diabetes self-management that are both helping to improve therapy adherence and outcomes, and reduce the human and economic burden of diabetes. Roche’s innovative systems are ensuring accurate and safe diabetes management both at home and on the move.
I’ve had diabetes for 25 years and my doctor suggested insulin pump therapy when I was pregnant to achieve a steady blood glucose level. Since I’ve been using an insulin pump, I have lived very well with it.
Fast, intuitive monitoring
Today, blood glucose monitoring devices are smaller, faster and more sophisticated than before. Meters and insulin pumps can interactively communicate with each other via Bluetooth with pump therapy emerging as an alternative to multiple daily injections for some patients. Information management applications transmit blood glucose data from the meter to a smartphone, and then directly to the healthcare provider via cloud-based platforms, empowering people with diabetes and their doctors to confront the disease head on.
With regular self-monitoring, heightened awareness of glucose levels and the structured approach of personalised diabetes management, people with diabetes gain a better understanding of their metabolism and glycaemic control, have greater peace of mind and are able to regain a sense of freedom. Roche has consistently invested in high-quality solutions for patients, giving them the tools they need to stay in control of their health and live full, active and unrestricted lives.
1 - International Diabetes Federation, IDF Diabetes Atlas, 7th edition, IDF, 2015. Last accessed March 2016 at www.diabetesatlas.org/
2 - Ibid.
3 - Ibid.
4 - World Health Organization, ‘Global Health Estimates: Deaths by Cause, Age, Sex and Country, 2000-2012’. Geneva, WHO, 2014. Last accessed March 2016 at www.who.int/healthinfo/global_burden_disease/en/.
5 - Mathers CD, Loncar D. (2006), ‘Projections of global mortality and burden of disease from 2002 to 2030’, PLoS Med, 3(11): e442.
6 - International Diabetes Federation, IDF Diabetes Atlas, 7th edition, IDF, 2015. Last accessed March 2016 at www.diabetesatlas.org/